New San Diego Biotech Charts Stem-Cell Therapies for Heart Disease – Xconomy
|
New San Diego Biotech Charts Stem–Cell Therapies for Heart Disease
Xconomy CardioCell, a new San Diego biotech spun out of privately held Stemedica Cell Technologies, stepped into the light today, saying it is beginning a mid-stage clinical study in the United States to evaluate the use its proprietary stem cells to treat … CardioCell Launches AMI Therapy Trials in U.S., KazakhstanDrug Discovery & Development |
